RegenxBio has a total of 492 patents globally, out of which 26 have been granted. Of these 492 patents, more than 85% patents are active. The United States of America is where RegenxBio has filed the maximum number of patents, followed by Canada and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of RegenxBio.
RegenxBio was founded in 2008. RegenxBio is a biotechnology business. The company’s primary areas of interest include recombine and adenoid-associated viral gene therapy development, marketing, and licensing.
Do read about some of the most popular patents of RegenxBio which have been covered by us in this article and also you can find RegenxBio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over RegenxBio patent portfolio.
How many patents does RegenxBio have?
RegenxBio has a total of 492 patents globally. These patents belong to 71 unique patent families. Out of 492 patents, 423 patents are active.
How Many Patents did RegenxBio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | RegenxBio Applications Filed | RegenxBio Patents Granted |
| 2023 | 18 | 3 |
| 2022 | 38 | 13 |
| 2021 | 129 | 5 |
| 2020 | 105 | – |
| 2019 | 72 | 2 |
| 2018 | 59 | 2 |
| 2017 | 31 | 1 |
| 2016 | 23 | – |
| 2015 | 3 | – |
| 2014 | 14 | – |
How many RegenxBio patents are Alive/Dead?
Worldwide Patents
How Many Patents did RegenxBio File in Different Countries?
Countries in which RegenxBio Filed Patents
| Country | Patent |
| United States Of America | 47 |
| Canada | 44 |
| Australia | 39 |
| Europe | 38 |
| Israel | 34 |
| Hong Kong (S.A.R.) | 33 |
| Korea (South) | 32 |
| Singapore | 23 |
| Japan | 23 |
| Brazil | 21 |
| Mexico | 20 |
| Argentina | 18 |
| Taiwan | 17 |
| New Zealand | 7 |
| Russia | 4 |
| China | 4 |
| Eurasia | 3 |
| India | 3 |
| South Africa | 2 |
| Paraguay | 2 |
| Uruguay | 2 |
| Serbia | 1 |
| Slovakia | 1 |
| Bolivia | 1 |
| Austria | 1 |
| Colombia | 1 |
| Denmark | 1 |
| Lithuania | 1 |
| Croatia | 1 |
| Slovenia | 1 |
| Poland | 1 |
| Malta | 1 |
| Portugal | 1 |
| Hungary | 1 |
| Malaysia | 1 |
| Spain | 1 |
| Norway | 1 |
Where are Research Centers of RegenxBio Patents Located?
10 Best RegenxBio Patents
WO2017136202A1 is the most popular patent in the RegenxBio portfolio. It has received 26 citations so far from companies like Voyager Therapeutics, Prevail Therapeutics, Ucl Business.
Below is the list of 10 most cited patents of RegenxBio:
| Publication Number | Citation Count |
| WO2017136202A1 | 26 |
| WO2019079494A1 | 23 |
| US20210010025A1 | 19 |
| WO2017181021A1 | 18 |
| WO2019067540A1 | 15 |
| US20180071373A1 | 14 |
| WO2020033842A1 | 14 |
| WO2019212922A1 | 13 |
| WO2019212921A1 | 11 |
| US20190038777A1 | 10 |
What are RegenxBio key innovation segments?
What Technologies are Covered by RegenxBio?
The chart below distributes patents filed by RegenxBio